Form 4: GeneDx CFO Sells Shares for Tax After RSU Vesting

GeneDx Holdings Corp. CFO Kevin Feeley reported the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Summary

• Kevin Feeley, Chief Financial Officer of GeneDx Holdings Corp. (WGS), reported transactions on December 16, 2025.
• 7,197 Restricted Stock Units (RSUs) vested and converted into Class A Common Stock.
• Concurrently, Feeley sold 3,855 shares of Class A Common Stock to cover tax withholding obligations related to the RSU vesting.
• These sales occurred at weighted average prices ranging from $138.93 to $150.75 per share.
• Following these transactions, Feeley directly owns 8,731 shares of Class A Common Stock.
• He also beneficially owns contingent rights to receive up to 113,504 additional shares via RSUs and options to purchase up to 25,906 shares, which vest according to their respective terms.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction involving the vesting of equity awards and a non-discretionary sale to cover tax obligations. This is a standard event and does not indicate significant positive or negative sentiment regarding the company's performance or outlook.

Positives

• The vesting of 7,197 RSUs indicates continued compensation and retention of a key executive.
• The company's stock price demonstrated strength, with shares sold at prices between $138.93 and $150.75.

Negatives

• The sale of 3,855 shares, even for tax purposes, reduces the CFO's direct equity ownership in the company.

Future Outlook

Remaining Restricted Stock Units (RSUs) and options held by the reporting person are expected to vest according to their respective terms, subject to continued service to the Issuer.

Management Comments

• "The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs."
• "The sale was to satisfy tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary transaction by the Reporting Person."

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, common across all industries for executives receiving equity compensation. It does not provide specific industry-related insights or trends.

Comparison to Industry Standards

• "Sell to cover" transactions are a standard and common practice for executives to manage tax liabilities arising from the vesting of equity awards, aligning with typical corporate compensation structures across various industries. No specific comparable companies or projects are mentioned in the filing.

Stakeholder Impact

• Shareholders: A minor reduction in the CFO's direct equity ownership due to tax-related sales, but overall beneficial ownership (including unvested awards) remains substantial.
• Employees: No direct impact.
• Customers, Suppliers, Creditors: No direct impact.

Next Steps

• Remaining Restricted Stock Units (RSUs) and options held by the reporting person will vest according to their respective terms.

Key Dates

Keywords

GeneDx Holdings Corp., WGS, Form 4, Insider Transaction, CFO, Stock Sale, RSU, Restricted Stock Unit, Tax Withholding, Equity Compensation